Barclays
CRTX

Barclays’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Barclays’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,542
Closed -$68K – 7947
2013
Q4 		$68K Sell
7,542
-1,876
-20% -$17.8K ﹤0.01% 5967
2013
Q3 		$85K Buy
9,418
+1,680
+22% +$15.1K ﹤0.01% 5756
2013
Q2 		$62K Buy
+7,738
New +$65.2K ﹤0.01% 6166

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Barclays's CRTX Position: Q1 2014 in Review

Barclays sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 7,542 shares — an estimated $68K sold.

Barclays first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $85K in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Barclays reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Barclays sold 7,542 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $68K.
  • Barclays first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Barclays's CORNERSTONE THERAPEUTICS INC position peaked at $85K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.